IL Receptor, IL-1beta, ILReceptor, Ilaris, ACZ 885
Canakinumab (ACZ885) is a recombinant human monoclonal antibody that potently neutralizes IL-1beta, exhibiting anti-inflammatory effects in both in vitro assays and in vivo models of autoimmune and cardiovascular diseases. Its application extends to research areas including gout, atherosclerosis, and cytokine-driven inflammation.
Konzentration:
2.74 mg/mL
Molekulargewicht:
145.18 kDa
Reinheit:
98.80% (May vary between batches)
CAS Nummer:
[914613-48-2]
Target-Kategorie:
Interleukin,IL Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten